GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lisata Therapeutics Inc (FRA:8NE) » Definitions » Cyclically Adjusted Book per Share

Lisata Therapeutics (FRA:8NE) Cyclically Adjusted Book per Share : €72.01 (As of Mar. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Lisata Therapeutics Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Lisata Therapeutics's adjusted book value per share for the three months ended in Mar. 2024 was €4.762. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €72.01 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Lisata Therapeutics's average Cyclically Adjusted Book Growth Rate was -30.30% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -32.30% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -29.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Lisata Therapeutics was 51.50% per year. The lowest was -33.80% per year. And the median was -17.30% per year.

As of today (2024-06-07), Lisata Therapeutics's current stock price is €2.80. Lisata Therapeutics's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €72.01. Lisata Therapeutics's Cyclically Adjusted PB Ratio of today is 0.04.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Lisata Therapeutics was 1.93. The lowest was 0.01. And the median was 0.07.


Lisata Therapeutics Cyclically Adjusted Book per Share Historical Data

The historical data trend for Lisata Therapeutics's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lisata Therapeutics Cyclically Adjusted Book per Share Chart

Lisata Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 323.81 231.71 146.96 102.12 79.69

Lisata Therapeutics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 97.87 93.23 88.13 79.69 72.01

Competitive Comparison of Lisata Therapeutics's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Lisata Therapeutics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lisata Therapeutics's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lisata Therapeutics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Lisata Therapeutics's Cyclically Adjusted PB Ratio falls into.



Lisata Therapeutics Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Lisata Therapeutics's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=4.762/131.7762*131.7762
=4.762

Current CPI (Mar. 2024) = 131.7762.

Lisata Therapeutics Quarterly Data

Book Value per Share CPI Adj_Book
201406 246.585 100.560 323.132
201409 206.662 100.428 271.171
201412 193.524 99.070 257.413
201503 177.198 99.621 234.393
201506 159.988 100.684 209.394
201509 133.486 100.392 175.217
201512 57.556 99.792 76.003
201603 31.124 100.470 40.822
201606 13.629 101.688 17.662
201609 17.554 101.861 22.709
201612 8.475 101.863 10.964
201703 -1.240 102.862 -1.589
201706 81.517 103.349 103.939
201709 71.198 104.136 90.096
201712 67.501 104.011 85.520
201803 57.922 105.290 72.493
201806 57.754 106.317 71.584
201809 53.659 106.507 66.390
201812 50.418 105.998 62.679
201903 44.356 107.251 54.499
201906 38.146 108.070 46.514
201909 33.030 108.329 40.179
201912 26.690 108.420 32.440
202003 22.002 108.902 26.624
202006 28.897 108.767 35.010
202009 24.779 109.815 29.734
202012 20.677 109.897 24.794
202103 23.351 111.754 27.535
202106 21.950 114.631 25.233
202109 21.044 115.734 23.961
202112 20.483 117.630 22.946
202203 19.911 121.301 21.630
202206 19.298 125.017 20.341
202209 9.252 125.227 9.736
202212 7.956 125.222 8.372
202303 7.118 127.348 7.366
202306 6.579 128.729 6.735
202309 6.096 129.860 6.186
202312 5.417 129.419 5.516
202403 4.762 131.776 4.762

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Lisata Therapeutics  (FRA:8NE) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Lisata Therapeutics's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=2.80/72.01
=0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Lisata Therapeutics was 1.93. The lowest was 0.01. And the median was 0.07.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Lisata Therapeutics Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Lisata Therapeutics's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Lisata Therapeutics (FRA:8NE) Business Description

Industry
Traded in Other Exchanges
Address
110 Allen Road, 2nd Floor, Basking Ridge, NJ, USA, 07920
Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases.

Lisata Therapeutics (FRA:8NE) Headlines

No Headlines